Carasent ASA: Daniel Öhman appointed new CEO

June 16, 2022

The board of directors of Carasent ASA ("Carasent" or "the Company") has today
appointed Daniel Öhman as the Company's new Chief Executive Officer (CEO). He
will succeed Dennis Höjer who has been CEO since December 2020. Öhman will start
no later than 2 January 2023.

Daniel Öhman is at present CEO of GHP Speciality Care, a role he has held since
2013. During Öhman's leadership, GHP Specialty Care's valuation increased from
370 MSEK to 2 450 MSEK, turnover doubled, and EBITDA increased from 50 MSEK to
200 MSEK. Öhman was also instrumental in the development of GHP Solutions, a
business area within which healthcare is sold as a subscription service and
continuously refined using a uniquely comprehensive data layer.

"We are pleased to welcome Daniel Öhman to Carasent. He has done an impressive
job growing GHP Speciality Care the last nine years. His industry knowledge and
experience of both organic and international growth is very much aligned with
Carasent's ambitions going forward. We are confident that this change in
management will benefit our customers, employees, and investors", says Johan
Lindqvist, Chairman of the Board.

Öhman has been with GHP Speciality Care in various positions since 2006, and has
managed the company during heavy expansion, both financially and geographically.
He has experience from growing business in the UK, Czech Republic, the Middle
East, Denmark and Norway.

"I look forward to joining Carasent and become a part of this exciting company.
As a customer I know them well. Carasent is not the largest provider, but their
platform is the best. The challenge is now to grow, and to become number one.",
says Daniel Öhman.

The Board extends its gratitude to Dennis Höjer, who will continue as acting CEO
until Daniel Öhman assumes the position.

About the Company:
Carasent ASA was founded in 1997. In the spring of 2018, the Company acquired
Evimeria EMR AB, a Swedish company that delivers a cloud based electronic health
record (EHR). Since then, three acquisitions have been completed, adding new
products to the portfolio and new customer segments to the customer list.
Carasent's main products are cloud based EHR solutions and a broad ecosystem of
platform services, including solutions for patient communication and business
intelligence. This provides customers with a full-service offering. Carasent's
strategy is to develop and expand digitalization, helping customers provide
efficient health care services of high quality.

For further information, please contact:

Johan Lindqvist, Chairman Carasent ASA Phone: +46 733 550935
Daniel Öhman Phone: +46 708 553707

More Press releases